May 09, 2023 / 06:20PM GMT
Travis Lee Steed - BofA Securities, Research Division - MD
Good morning, everybody, or afternoon, depending on where you are. This is Travis Steed, Bank of America medical device analyst, and up next we have Axonics. We've got Ray Cohen, CEO; and Dan Dearen, CFO. Thanks for joining us.
Ray, maybe just -- I don't know if you had any opening remarks coming out of Q1 that you wanted to touch on or jump into Q&A.
Raymond W. Cohen - Axonics, Inc. - CEO & Director
Sure. We're glad most people are starting to have made their deductibles now. So things are looking more, things are looking better.
Questions and Answers:
Travis Lee Steed - BofA Securities, Research Division - MDAll right. Good. Maybe we'll start with just like thinking through like the progression of Q1, like, I guess, obviously, January is probably down a lot with seasonality. Maybe just think through like how the business is shaping up over the course of Q1 and Q2 momentum into April sequentially what you're seeing on the ground?